ADDITIONAL IMS ASSAYS FOR THE BAYER ADVIA IMS SYSTEM (INVITRO DIAGNOSTIC SYSTEM WITH 5 ADDITIONAL ASSAYS)— 510(k) K993711

Substantially Equivalent

Bayer Corp.

FDA 510(k) clearance K993711 for ADDITIONAL IMS ASSAYS FOR THE BAYER ADVIA IMS SYSTEM (INVITRO DIAGNOSTIC SYSTEM WITH 5 ADDITIONAL ASSAYS), Substantially Equivalent on 1999-12-16. Applicant: Bayer Corp..

Clearance details

Applicant: Bayer Corp.
Product code: Code JZG
Advisory panel: Immunology
Date received: 1999-11-03
Decision date: 1999-12-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.